Insider Transactions in Q2 2022 at Privia Health Group, Inc. (PRVA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2022
|
Thomas Bartrum |
SELL
Open market or private sale
|
Direct |
48
-0.05%
|
$1,440
$30.0 P/Share
|
|
Jun 28
2022
|
Thomas Bartrum |
BUY
Exercise of conversion of derivative security
|
Direct |
48
+0.05%
|
$96
$2.0 P/Share
|
|
Jun 28
2022
|
David Mountcastle EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
32
-0.04%
|
$960
$30.0 P/Share
|
|
Jun 28
2022
|
David Mountcastle EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32
+0.04%
|
$64
$2.0 P/Share
|
|
Jun 23
2022
|
Matthew Shawn Morris Director |
SELL
Open market or private sale
|
Direct |
77,534
-21.46%
|
$2,248,486
$29.31 P/Share
|
|
Jun 23
2022
|
Matthew Shawn Morris Director |
BUY
Exercise of conversion of derivative security
|
Direct |
77,534
+28.01%
|
$155,068
$2.0 P/Share
|
|
Jun 22
2022
|
Matthew Shawn Morris Director |
SELL
Open market or private sale
|
Direct |
69,843
-18.96%
|
$2,025,447
$29.39 P/Share
|
|
Jun 22
2022
|
Matthew Shawn Morris Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69,843
+26.72%
|
$139,686
$2.0 P/Share
|
|
Jun 21
2022
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
60,000
-21.12%
|
$1,740,000
$29.34 P/Share
|
|
Jun 21
2022
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+27.6%
|
$120,000
$2.0 P/Share
|
|
Jun 21
2022
|
Thomas Bartrum |
SELL
Open market or private sale
|
Direct |
10,000
-5.05%
|
$290,000
$29.31 P/Share
|
|
Jun 21
2022
|
Thomas Bartrum |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.98%
|
$20,000
$2.0 P/Share
|
|
Jun 06
2022
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,000
-29.11%
|
$1,000,000
$25.01 P/Share
|
|
Jun 06
2022
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+22.55%
|
$80,000
$2.0 P/Share
|
|
Jun 06
2022
|
Thomas Bartrum |
SELL
Open market or private sale
|
Direct |
10,000
-9.87%
|
$250,000
$25.01 P/Share
|
|
Jun 06
2022
|
Thomas Bartrum |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.98%
|
$20,000
$2.0 P/Share
|
|
May 31
2022
|
Thomas Bartrum |
BUY
Grant, award, or other acquisition
|
Direct |
63,964
+41.18%
|
-
|
|
May 27
2022
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,425
+33.06%
|
-
|
|
May 27
2022
|
Jeffrey B Butler Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,425
+0.2%
|
-
|
|
May 27
2022
|
Jaewon Ryu Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,425
+39.51%
|
-
|
|
May 27
2022
|
William M Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,425
+33.06%
|
-
|
|
May 27
2022
|
David P King Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,425
+33.06%
|
-
|
|
May 27
2022
|
Thomas A Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,425
+23.83%
|
-
|
|
Apr 20
2022
|
Thomas Bartrum |
SELL
Open market or private sale
|
Direct |
10,000
-26.74%
|
$270,000
$27.93 P/Share
|
|
Apr 20
2022
|
Thomas Bartrum |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+21.1%
|
$20,000
$2.0 P/Share
|
|
Apr 20
2022
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-17.04%
|
$540,000
$27.93 P/Share
|
|
Apr 20
2022
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+14.56%
|
$40,000
$2.0 P/Share
|
|
Apr 04
2022
|
Pamplona Capital Partners Iii, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
4,804,754
+19.35%
|
-
|
|
Apr 04
2022
|
Pamplona Capital Partners Iii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
4,804,754
-24.0%
|
-
|
|
Apr 01
2022
|
Nancy G Cocozza Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,073
+50.0%
|
-
|
|
Apr 01
2022
|
David Mountcastle EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,833
+37.58%
|
-
|